First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer
Tóm tắt
Từ khóa
Tài liệu tham khảo
Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696
Bill-Axelson, 2005, Radical prostatectomy versus watchful waiting in early prostate cancer, N Engl J Med, 352, 1977, 10.1056/NEJMoa043739
Heidenreich, 2011, EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease, Eur Urol, 59, 61, 10.1016/j.eururo.2010.10.039
Salomon, 1999, Value of ultrasound-guided systematic sextant biopsies in prostate tumor mapping, Eur Urol, 35, 289, 10.1159/000019863
Berg, 2013, Is it possible to predict low-volume and insignificant prostate cancer by core needle biopsies?, APMIS, 121, 257, 10.1111/j.1600-0463.2012.02965.x
Washington, 2012, Transrectal ultrasonography-guided biopsy does not reliably identify dominant cancer location in men with low-risk prostate cancer, BJU Int, 110, 50, 10.1111/j.1464-410X.2011.10704.x
Belas, 2012, Low accuracy of routine ultrasound-guided systematic 12-core biopsies in prostate tumor mapping, Can J Urol, 19, 6366
Li, 2013, Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml, Eur Urol
Irani, 2013, Is an extended 20-core prostate biopsy protocol more efficient than the standard 12-core? A randomized multicenter trial, J Urol, 190, 77, 10.1016/j.juro.2012.12.109
Ferro, 2013, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml, PLoS ONE, 8, e67687, 10.1371/journal.pone.0067687
Tomlins, 2011, Urine TMPRSS2:ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA, Sci Transl Med, 3, 94ra72, 10.1126/scitranslmed.3001970
Emberton, 2013, Has Magnetic Resonance-Guided Biopsy of the Prostate Become the Standard of Care?, Eur Urol, 64, 720, 10.1016/j.eururo.2013.06.050
Rais-Bahrami, 2013, Utility of multiparametric MRI suspicion levels in detecting prostate cancer, J Urol, 190, 1721, 10.1016/j.juro.2013.05.052
Vos, 2013, Assessment of Prostate Cancer Aggressiveness Using Dynamic Contrast-enhanced Magnetic Resonance Imaging at 3 T, Eur Urol, 64, 448, 10.1016/j.eururo.2013.05.045
Delongchamps, 2013, Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies, J Urol, 189, 493, 10.1016/j.juro.2012.08.195
Fiard, 2013, Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion, Urology, 81, 1372, 10.1016/j.urology.2013.02.022
Sonn, 2013, Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device, J Urol, 189, 86, 10.1016/j.juro.2012.08.095
Vourganti, 2012, Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies, J Urol, 188, 2152, 10.1016/j.juro.2012.08.025
Moore, 2013, Standards of Reporting for MRI-targeted Biopsy Studies (START) of the Prostate: recommendations from an international working group, Eur Urol, 64, 544, 10.1016/j.eururo.2013.03.030
Puech, 2013, Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study, Radiology, 268, 461, 10.1148/radiol.13121501
Renard-Penna, 2013, Accuracy of high resolution (1.5 tesla) pelvic phased array magnetic resonance imaging (MRI) in staging prostate cancer in candidates for radical prostatectomy: results from a prospective study, Urol Oncol, 31, 448, 10.1016/j.urolonc.2011.02.017
Dickinson, 2011, Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting, Eur Urol, 59, 477, 10.1016/j.eururo.2010.12.009
Portalez, 2012, Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients, Eur Urol, 62, 986, 10.1016/j.eururo.2012.06.044
Baumann, 2012, Prostate biopsy tracking with deformation estimation, Med Image Anal, 16, 562, 10.1016/j.media.2011.01.008
Harnden, 2008, The clinical management of patients with a small volume of prostatic cancer on biopsy: what are the risks of progression? A systematic review and meta-analysis, Cancer, 112, 971, 10.1002/cncr.23277
Ploussard, 2010, Pathological findings and prostate specific antigen outcomes after radical prostatectomy in men eligible for active surveillance-does the risk of misclassification vary according to biopsy criteria?, J Urol, 183, 539, 10.1016/j.juro.2009.10.009
Abdollah, 2011, The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy, BJU Int, 108, 366, 10.1111/j.1464-410X.2010.09876.x
Metcalfe, 2009, Current strategies for monitoring men with localised prostate cancer lack a strong evidence base: observational longitudinal study, Br J Cancer, 101, 390, 10.1038/sj.bjc.6605181
Siddiqui, 2013, Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy, Eur Urol, 64, 713, 10.1016/j.eururo.2013.05.059
Mozer, 2009, Mapping of transrectal ultrasonographic prostate biopsies: quality control and learning curve assessment by image processing, J Ultrasound Med, 28, 455, 10.7863/jum.2009.28.4.455
Rooij, 2013, Cost-effectiveness of Magnetic Resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective, Eur Urol